Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
スポンサーリンク
概要
- 論文の詳細を見る
- 2010-01-15
著者
-
MORITA Yasuyoshi
Department of Hematology, Kinki University School of Medicine
-
KANAMARU Akihisa
Department of Hematology, Kinki University School of Medicine
-
MIYAZAKI Yasushi
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
IMANISHI Daisuke
Department of Hematology, Molecular Medicine Unit, Atomic Bomb Disease Institute, Nagasaki Universit
-
YAGASAKI Fumiharu
Department of Hematology, Saitama Medical University Hospital
-
TANIMOTO Mitsune
Blood Transfusion Division, Department of Internal Medicine II, Okayama University Graduate School o
-
KURIYAMA Kazutaka
Blood Immunology Laboratory, School of Health Sciences, Faculty of Medicine and University Hospital,
-
KOBAYASHI Toru
Department of Hematopoietic Pathobiology and Medical Oncology, Mie University Graduate School of Med
-
IMOTO Shion
Hyogo Prefectural Red Cross Blood Center
-
OHNISHI Kazunori
Third Department of Internal Medicine, Hamamatsu University School of Medicine
-
NAOE Tomoki
Department of Hematology and Oncology, Nagoya University Graduate School of Medicine
-
OHNO Ryuzo
Aichi Cancer Center
-
三木 義男
癌研ゲノムセンター
-
Morishima Y
Department Of Hematology Kinki University School Of Medicine
-
Miyazaki Yoshitsugu
長崎大学 第二内科
-
Moriwaki Yuji
長崎大学大学院医歯薬学総合研究科附属原爆後障害医療研究施設 分子治療研究分野
-
Tsuboi Naoya
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
TAWARA Masayuki
Nagasaki CML Study Group
-
KURIYAMA Kazutaka
Nagasaki CML Study Group
-
Naoe Tomoki
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Tsuboi Naoya
Cardiovascular Center Nagoya Daini Red Cross Hospital
-
Tsuboi Naoya
Division Of Cardiology Nagoya Daini Red Cross Hospital
-
Takahashi Masatomo
Division Of Hematology And Oncology Department Of Internal Medicine St. Marianna University School O
-
Takahashi Masatomo
聖マリアンナ医科大学 血液･腫瘍内科
-
Matsushima Takafumi
Department Of Hematology St. Marianna University School Of Medicine
-
谷脇 雅文
Department Of Environmental Systems Engineering Kochi University Of Technology
-
ANDO Kiyoshi
Tokai University
-
Taniwaki Masafumi
国立がんセンター中央病院 血液内科
-
Ohno R
Aichi Cancer Center
-
Ohno Ryuzo
琉球大学 医学部血液免疫検査学分野
-
Naoe Tomoki
名古屋大学 医学系研究科血液･腫瘍内科学
-
Naoe Tomoki
大垣市民病院 血液内科
-
Tsuchida Masahiro
産業医科大学 小児科学
-
Kanamaru A
Department Of Hematology Kinki University School Of Medicine
-
Tanimoto M
Blood Transfusion Division Department Of Internal Medicine Ii Okayama University Graduate School Of
-
Tanimoto Mitsune
国立がんセンター中央病院 造血幹細胞移植グループ
-
Tanimoto Mitsune
Okayama Univ. Hospital Okayama Jpn
-
Tanimoto Mitsune
岡山大学 医歯総研究 第2内科
-
Ohnishi K
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Ohnishi Kazunori
東北大学病院 血液･免疫科
-
Takahashi Masatomo
St. Marianna Univ. School Of Medicine Kawasaki Jpn
-
Kitamura Kunio
名古屋大学 医学系研究科血液･腫瘍内科学
-
Murata Takashi
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
Kuriyama K
Blood Immunology Laboratory School Of Health Sciences Faculty Of Medicine And University Hospital Un
-
Tomonaga Masao
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Taniwaki M
Celgene Kk
-
Tanimoto Mitsune
Blood Transfusion Division Department Of Internal Medicine Ii Okayama University Graduate School Of
-
Tanimoto Mitsune
名古屋大学 第1内科
-
Mishima Yuko
Cancer Chemotherapy Center Clinical Chemotherapy Japanese Foundation For Cancer Research
-
Matsumoto-mishima Yuko
癌研究会癌化学療法センター 臨床研究部
-
Naoe T
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Odagiri Keiichi
Department Of Medicine Hamamatsu Red Cross Hospital
-
Imanishi Daisuke
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Imanishi Daisuke
Department Of Hematology Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki University G
-
Matsuno Y
Department Of Surgical Pathology Hokkaido University Hospital
-
Matsuno Yoshihiro
Department Of Chemotherapy Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospita
-
Tomonaga Masao
Department Of Hematology Atomic Bomb Disease Institute Nagasaki University School Of Medicine
-
Oshimi Kazuo
Division Of Hematology Department Of Medicine Juntendo University School Of Medicine
-
Taniwaki Masafumi
Third Department Of Internal Medicine Kyoto Prefectural University Of Medicine
-
Taniwaki Masafumi
Department Of Molecular Hematology And Oncology Kyoto Prefectural University Of Medicine Graduate Sc
-
Oshimi Kazuo
Department Of Hematology Juntendo University Tokyo
-
Ohnishi Kazunori
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Morishima Yasuo
Department Of Hematology And Cell Therapy Aichi Cancer Center Central Hospital
-
Kanamaru Akihisa
Department Of Hematology Kinki University School Of Medicine
-
Kanamaru Akihisa
Division Of Hematology Nephrology And Rheumatology Department Of Internal Medicine Kinki University
-
Naoe Tomoki
Department Of Hematologly And Oncology Nagoya University School Of Medicine
-
MITSUI Yoko
Department of Surgery
-
Tomonaga Masao
Department Of Hematology Molecular Medicine Unit Atomic Disease Institute Nagasaki University Gradua
-
Tomonaga Masao
Department Of Hematology Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki University
-
Morishima Yasuo
Department Of Hematology And Chemotherapy
-
Oshimi Kazuo
Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Yagasaki Fumiharu
Department Of Hematology Saitama Medical University Hospital
-
Murai Yoshiro
Department Of Hematology Tama Hokubu Medical Center
-
Taniwaki Masafumi
Department Of Hematology/oncology Kyoto Prefectural University Of Medicine
-
Kobayashi Tohru
Department Of Hematopoietic Pathobiology And Medical Oncology Mie University Graduate School Of Medi
-
Ohno Ryuzo
Department Of Medicine Iii Hamamatsu Medical School
-
Matsumoto Yosuke
Department Of Molecular Hematology And Oncology Graduate School Of Medical Science Kyoto Prefectural
-
Moriuchi Yukiyoshi
Nagasaki Cml Study Group Nagasaki Jpn
-
Miyazaki Yasushi
Department Of Hematology And Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki Universi
-
Yagasaki Fumiharu
Department Of Hematology Saitama Medical University
-
Miyazaki Yoshitsugu
Second Department Of Internal Medicine Nagasaki University Graduate School Of Biomedical Science
-
Miyazaki Yoshitsugu
The Second Department Of Internal Medicine Nagasaki University School Of Medicine
-
Taniwaki Masafumi
Department Of Clinical Molecular Genetics And Laboratory Medicine Kyoto Prefectural University Of Me
-
Taniwaki Masafumi
The Third Department Of Internal Medicine Kyoto Prefectural Medical School
-
Ohnishi Kazunori
Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Kyo T
Hiroshima Red Cross Hospital & Atomic‐bomb Survivors Hospital Hiroshima Jpn
-
Kikuchi Ako
Department Of Hematology/oncology Tokai University School Of Medicine
-
Kikuchi Ako
Tokai University
-
Ochi Kensuke
Laboratory Of Molecular Medicine Human Genome Center Institute Of Medical Science University Of Toky
-
Kinoshita Tomohiro
Department Of Hematology Nagoya University School Of Medicine
-
Takeyama K
National Cancer Center Hospital Tokyo Jpn
-
Naruse T
Department Of Hematology And Oncology Nagoya University Graduate School Of Medicine
-
Tanimoto Mitsune
Okayama Univ. Graduate School Of Medicine Okayama Jpn
-
Miyazaki Yasushi
Department Of Hematology Kinki University School Of Medicine
-
Odagiri Keiichi
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Ohnishi Kazunori
The Division Of Hematology Department Of Medicine Iii Hamamatsu University School Of Medicine
-
Ohashi K
Third Department Of Internal Medicine Hamamatsu University School Of Medicine
-
Kuriyama Kazutaka
Blood Immunology Laboratory School Of Health Sciences Faculty Of Medicine And University Hospital Un
-
Ohnishi Kazunori
Cancer Center Hamamatsu University School Of Medicine
-
Morishima Yasuo
Department Of Pathology And Oncology Institute Of Medical Science University Of Tokyo
-
Kanamaru Akihisa
Division Of Hematology And Oncology Department Of Medicine Tokai University School Of Medicine
-
Imanishi Daisuke
Department Of Hematology Molecular Medicine Unit Atomic Bomb Disease Institute Nagasaki University G
-
Takabayashi Maki
Department Of Internal Medicine And Clinical Immunology Yokohama City University Graduate School Of
-
Ando Kiyoshi
Department Of Hematology And Oncology Tokai University
-
Kobayashi Toru
Department Of Chemical Science And Technology Faculty Of Engineering The University Of Tokushima
-
Yagasaki Fumiharu
Department Of Public Health Shimane University Faculty Of Medicine
-
Ohmachi Ken
Department Of Cell Pathology Graduate School Of Medical Sciences Kumamoto University
-
Nakano Tatsunori
Second Departmant Of Medicine Nagoya City University Medical School
-
Fukushima Takuya
Department Of Hematology Nagasaki University Hospital
-
Kanamaru Akihisa
Department Of Hematology And Oncology Tokai University Hospital
-
Fujita Yasuyuki
Department Of Public Health Shimane University Faculty Of Medicine
-
Morita Yasuyoshi
Department of Hematology and Rheumatology, Kinki University Faculty of Medicine, Japan
-
KOBAYASHI Toru
Department of Agricultural and Biological Chemistry, Shinshu University
関連論文
- Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- Comparative analysis of remission induction therapy for high-risk MDS and AML progressed from MDS in the MDS200 study of Japan Adult Leukemia Study Group
- Promoter Hypermethylation of the DNA-Repair Gene O^6-Methylguanine-DNA Methyltransferase and p53 Mutation in Diffuse Large B-Cell Lymphoma
- Loss of O^6-Methylguanine-DNA Methyltransferase Protein Expression Is a Favorable Prognostic Marker in Diffuse Large B-Cell Lymphoma
- Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
- Management of infection in patients with acute leukemia during chemotherapy in Japan : questionnaire analysis by the Japan Adult Leukemia Study Group
- Donor cell leukemia after allogeneic peripheral blood stem cell transplantation : a case report and literature review
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- The clinical characteristics of CD7^+ CD56^+ acute myeloid leukemias other than M0
- Definite diagnosis in Japanese patients with protein C deficiency by identification of causative PROC mutations
- Phase I/II study of humanized anti-CD33 antibody conjugated with calicheamicin, gemtuzumab ozogamicin, in relapsed or refractory acute myeloid leukemia : final results of Japanese multicenter cooperative study
- Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy
- Mutational analysis of SOS1 gene in acute myeloid leukemia
- Clinical significance of minimal residual disease in patients with t(8;21) acute myeloid leukemia in Japan
- Evaluation of organ involvement in intravascular large B-cell lymphoma by ^F-fluorodeoxyglucose positron emission tomography
- Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis
- Sustained Remission after Rituximab-containing Chemotherapy for Intravascular Large B-cell Lymphoma
- Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
- Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
- Wilms' tumor 1 message and protein expression in bone marrow failure syndrome and acute leukemia
- Epigenetic Regulation of CD20 Protein Expression in a Novel B-Cell Lymphoma Cell Line, RRBL1, Established from a Patient Treated Repeatedly with Rituximab-Containing Chemotherapy
- BMI-1 Is Highly Expressed in M0-Subtype Acute Myeloid Leukemia
- Successful Treatment with Imatinib Mesylate of a CML Patient in Megakaryoblastic Crisis with Severe Fibrosis
- Comparison of leukopenia between cytarabine and behenoyl cytarabine in JALSG AML-89 consolidation therapy
- Safety and Efficacy of Autologous Progenitor Cell Transplantation for Therapeutic Angiogenesis in Patients With Critical Limb Ischemia
- Downregulation of microRNAs-143 and -145 in B-cell malignancies
- let-7 MicroRNA Functions as a Potential Growth Suppressor in Human Colon Cancer Cells(Molecular and Cell Biology)
- A Case of Interstitial Pneumonia Induced by Rituximab Therapy
- Successful cord blood transplantation for mycosis fungoides.
- Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
- Human T cell leukemia virus type-1 Tax activates human macrophage inflammatory protein-3α/CCL20 gene transcription via the NF-kB pathway
- Infectious complications during remission induction therapy in 577 patients with acute myeloid leukemia in the Japan Adult Leukemia Study Group studies between 1987 and 1991
- Chemical Speciation of Arsenic Species in Human Blood Serum by Liquid Chromatography Using a Phosphatidylcholine-Coated ODS Column with Detection by ICP-MS
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- Central nervous system involvement in intravascular large B-cell lymphoma : A retrospective analysis of 109 patients
- Establishment of a Stroma-Dependent Human Acute Myelomonocytic Leukemia Cell Line, NAMO-2, with FLT3 Tandem Duplication
- Recurrent Intramural Hematoma of the Small Intestine in a Severe Hemophilia A Patient with a High Titer of Factor VIII Inhibitor : A Case Report and Review of the Literature
- High Titer of ADAMTS13 Inhibitor Associated with Thrombotic Microangiopathy of the Gut and Skeletal Muscle after Allogeneic Hematopoietic Stem Cell Transplantation
- Apoptotic Cytotoxic Effects of a Histone Deacetylase Inhibitor, FK228, on Malignant Lymphoid Cells
- Efficacy of Rituximab Monotherapy for an Elderly Hemodialysis Patient with Primary Cardiac Lymphoma
- Japanese epidemiological survey with consensus statement on Japanese guidelines for treatment of iron overload in bone marrow failure syndromes
- Interaction of von Willebrand Factor with the Extracellular Matrix and Glycocalicin under Static Conditions^1
- Clinical features of adult acute leukemia with 11q23 abnormalities in Japan : a co-operative multicenter study
- High-resolution melting analysis for a reliable and two-step scanning of mutations in the tyrosine kinase domain of the chimerical bcr-abl gene.
- Recent advances in the treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia
- Combined Resection of the Aorta for an Esophageal Carcinoma invading the Aorta Through a Right Transthoracic Approach
- Spontaneous regression of aleukemic leukemia cutis harboring a NPM/RARA fusion gene in an infant with cutaneous mastosytosis
- PJ-451 Physical activity, Self-efficasy, and health-related quality of life outcomes 1 and 3 year after onset of acute myocardial infarction(Preventive Medicine/Epidemiology/Education 4 (H) : PJ75)(Poster Session (Japanese))
- Biology, Clinical Relevance, and Molecularly Targeted Therapy in Acute Leukemia with FLT3 Mutation
- Nucleophosmin : A versatile molecule associated with hematological malignancies
- Mechanism-based Therapy for Leukemia: A Lesson from Atra Therapy
- Karyotypically independent clones with del(11q) and trisomy 10 in acute myeloid leukemia : trisomy 10 may appear as an additional change
- Antitumor effect of arsenic trioxide in murine xenograft model
- Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype
- Stable Engraftment after a Conditioning Regimen with Fludarabine and Melphalan for Bone Marrow Transplantation from an Unrelated Donor
- Quality of Life in Adult Patients after Bone Marrow Transplantation
- The Effects of Unsupervised Exercise Training on Physical Activity and Physiological Factors after Supervised Cardiac Rehabilitation
- Irrespective of CD34 expression, lineage-committed cell fraction reconstitutes and re-establishes transformed Philadelphia chromosome-positive leukemia in NOD/SCID/IL-2Rγc^ mice
- Severe hemophilia A in a Japanese female caused by an F8-intron 22 inversion associated with skewed X chromosome inactivation
- Classic Polyarteritis Nodosa Presenting Rare Clinical Manifestations in a Patient with Hemophilia A
- A RELATION BETWEEN THE CONFIGURATION OF THE TLOOP AND THE CORONARY ARTERIOGRAPHY (I) : THE III CONFERENCE ON VECTORCARDIOGRAPHY
- Ectopic Expression of MAFB Gene in Human Myeloma Cells Carrying (14;20)(q32;q11) Chromosomal Translocations
- Acute myeloid leukemia in the elderly : 159 Nagoya case studies
- Follicular Lymphoma in Osaka, Japan : Histological Features and Chronological Change
- The Prophylactic Effect of Itraconazole Capsules and Fluconazole Capsules for Systemic Fungal Infections in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes : A Japanese Multicenter Randomized, Controlled Study
- Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines
- Temperature-responsive Poly(dehydroalanine)s : Diversifying Phase Transition Temperatures Utilizing α,α-Disubstituted Motif
- Toxic effects of arsenic (As^) and other metal ions on acute promelocytic leukemia cells
- Immunoglobulin Variable Region Structure and B-Cell Malignancies
- Current trends in the management of malignant lymphoma: new WHO classification, guidelines for high-dose therapy with HSCT, and new response criteria
- Feasibility of salvage chemotherapy for refractory or relapsed non-Hodgkin's lymphoma with two topoisomerase II inhibitors, MST-16 and VP-16
- Alcoholic Ketoacidosis Associated with Multiple Complications : Report of 3 Cases
- Immunoaffinity Purification and Characterization of CACGTG Sequence-Binding Proteins from Cultured Mammalian Cells Using an Anti c-Myc Monoclonal Antibody Recognizing the DNA-Binding Domain
- Autoimmune Hepatitis Accompanied by Idiopathic Thrombocytopenic Purpura and Sjogren's Syndrome
- Successful Resection of a Ruptured Hepatoblastoma Prior to Chemotherapy : Report of a Case
- Mesenteric pseudocyst of the sigmoid colon
- Molecular mechanisms of analgesia induced by opioids and ethanol : is the GIRK channel one of the keys?
- Involvement of G-protein-activated inwardly rectifying K^+ (GIRK) channels in opioid-induced analgesia
- Unique behavioural phenotypes of recombinant-inbred CXBK mice: partial deficiency of sensitivity to μ- and κ-agonists
- G protein-activated inwardly rectifying K^+ channel inhibition and rescue of weaver mouse motor functions by antidepressants
- Morphological characteristics of Nigorobuna Carassius auratus grandoculis called Io in Lake Nishino
- High dose Chemotherapy and Stem Cell Support in a Patient of Light- and Heavy-chain Deposition Disease with Abnormal Marrow Cell Surface Antigens and No Monoclonal protein
- Intensified consolidation therapy with dose-escalated doxorubicin did not improve the prognosis of adults with acute lymphoblastic leukemia : the JALSG-ALL97 study
- Expanded distribution of the T315I mutation among hematopoietic stem cells and progenitors in a chronic myeloid leukemia patient during imatinib treatment
- Selective KIT inhibitor KI-328 and HSP90 inhibitor show different potency against the type of KIT mutations recurrently identified in acute myeloid leukemia
- Trough plasma concentration of imatinib reflects BCR-ABL kinase inhibitory activity and clinical response in chronic-phase chronic myeloid leukemia : A report from the BINGO study
- A method for the microinjection into naturally spawned eggs of marine fish, especially cultured Pacific bluefin tuna Thunnus orientalis
- Virus-Associated Hemophagocytic Syndrome Caused by Pandemic Swine-Origin Influenza A (H1N1) in a Patient After Unrelated Bone Marrow Transplantation
- Synthesis of Polymethlsiloxane-Grafted Fluoropolymers and Properties for Hydrophobic Materials
- Inhibition of G Protein-Activated Inwardly Rectifying K^+ Channels by the Antidepressant Paroxetine
- Phase I trial of gemtuzumab ozogamicin in intensive combination chemotherapy for relapsed or refractory adult acute myeloid leukemia (AML) : Japan Adult Leukemia Study Group (JALSG)-AML206 study
- Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
- A novel insertion mutation of K294RGG within BCR-ABL kinase domain confers imatinib resistance : sequential analysis of the clonal evolution in a patient with chronic myeloid leukemia in blast crisis
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation : macrophage-targeted steroid therapy
- Mutation of ARHGAP9 in patients with coronary spastic angina
- Randomized comparison of fixed-schedule versus response-oriented individualized induction therapy and use of ubenimex during and after consolidation therapy for elderly patients with acute myeloid leukemia : the JALSG GML200 Study
- Efficacy and safety of human adipose tissue-derived mesenchymal stem cells for supporting hematopoiesis
- Successful Allogeneic Hematopoietic Stem Cell Transplantation in a Young Patient with Richter Syndrome Presenting with Chronic Lymphocytic Leukemia and Diffuse Large B-Cell Lymphoma with Different Cell Origins